Home>>Signaling Pathways>> Ox Stress Reagents>> Antioxidants>>DL-Sulforaphane Glutathione

DL-Sulforaphane Glutathione (Synonyms: SFN-glutathione, SFN-GSH, Sulforaphane-GSH)

Catalog No.GC52368

A metabolite of sulforaphane

Products are for research use only. Not for human use. We do not sell to patients.

DL-Sulforaphane Glutathione Chemical Structure

Cas No.: 289711-21-3

Size Price Stock Qty
1 mg
$45.00
In stock
5 mg
$179.00
In stock
10 mg
$336.00
In stock
25 mg
$783.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

DL-Sulforaphane glutathione is a metabolite of the class I and II histone deacetylase (HDAC) inhibitor and anticancer agent sulforaphane .1 It increases mRNA expression of the genes encoding glutathione S-transferase A1 (GSTA1) and the UDP-glucuronosyltransferase (UGT) isoform UGT1A1 in HepG2 cells when used at a concentration of 15 µM.2

1.Wang, H., Khor, T.O., Yang, Q., et al.Pharmacokinetics and pharmacodynamics of phase II drug metabolizing/antioxidant enzymes gene response by anticancer agent sulforaphane in rat lymphocytesMol. Pharmacol.9(10)2819-2827(2012) 2.Basten, G.P., Bao, Y., and Williamson, G.Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cellsCarcinogenesis23(8)1399-1404(2002)

Reviews

Review for DL-Sulforaphane Glutathione

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for DL-Sulforaphane Glutathione

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.